In other studies performed in China [7, 11], higher pathogenic variant frequencies ranging from 0.54 to 1.6% were observed in BRCA1 and BRCA2 negative early-onset and/or familial breast cancer cases. This evidence concerns the gene BRCA2 and breast carcinoma.